344 related articles for article (PubMed ID: 22941884)
1. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
Glasgow CG; El-Chemaly S; Moss J
Eur Respir Rev; 2012 Sep; 21(125):196-206. PubMed ID: 22941884
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic involvement in lymphangioleiomyomatosis.
Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
[TBL] [Abstract][Full Text] [Related]
3. Involvement of lymphatics in lymphangioleiomyomatosis.
Glasgow CG; Taveira-DaSilva A; Pacheco-Rodriguez G; Steagall WK; Tsukada K; Cai X; El-Chemaly S; Moss J
Lymphat Res Biol; 2009 Dec; 7(4):221-8. PubMed ID: 20143921
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic manifestations of lymphangioleiomyomatosis.
Gupta R; Kitaichi M; Inoue Y; Kotloff R; McCormack FX
Lymphology; 2014 Sep; 47(3):106-17. PubMed ID: 25420303
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
[TBL] [Abstract][Full Text] [Related]
6. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis: a disease involving the lymphatic system.
Seyama K; Kumasaka T; Kurihara M; Mitani K; Sato T
Lymphat Res Biol; 2010 Mar; 8(1):21-31. PubMed ID: 20235884
[TBL] [Abstract][Full Text] [Related]
8. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Souma S; Kashiwagi S; Hebisawa A; Sato T; Kubo H; Gomi K; Shibuya K; Fukuchi Y; Suda K
Am J Surg Pathol; 2005 Oct; 29(10):1356-66. PubMed ID: 16160479
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.
Krymskaya VP
Proc Am Thorac Soc; 2008 Jan; 5(1):119-26. PubMed ID: 18094094
[TBL] [Abstract][Full Text] [Related]
11. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
Inoue Y; King TE; Barker E; Daniloff E; Newman LS
Am J Respir Crit Care Med; 2002 Sep; 166(5):765-73. PubMed ID: 12204879
[TBL] [Abstract][Full Text] [Related]
13. Lymphangioleiomyomatosis: what do we know and what are we looking for?
Harari S; Torre O; Moss J
Eur Respir Rev; 2011 Mar; 20(119):34-44. PubMed ID: 21357890
[TBL] [Abstract][Full Text] [Related]
14. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
17. Lymphangioleiomyomatosis: Current understanding and potential treatments.
Moir LM
Pharmacol Ther; 2016 Feb; 158():114-24. PubMed ID: 26713679
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
Liu HJ; Krymskaya VP; Henske EP
Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
Cai X; Pacheco-Rodriguez G; Fan QY; Haughey M; Samsel L; El-Chemaly S; Wu HP; McCoy JP; Steagall WK; Lin JP; Darling TN; Moss J
Am J Respir Crit Care Med; 2010 Dec; 182(11):1410-8. PubMed ID: 20639436
[TBL] [Abstract][Full Text] [Related]
20. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
Yue M; Pacheco G; Cheng T; Li J; Wang Y; Henske EP; Schuger L
Am J Pathol; 2016 Jul; 186(7):1825-1836. PubMed ID: 27289491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
